A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
Condition(s):Rheumatoid ArthritisLast Updated:July 26, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Rheumatoid ArthritisLast Updated:July 26, 2018Completed
Condition(s):Patients Receiving PrednisoneLast Updated:August 2, 2016Completed
Condition(s):Heart FailureLast Updated:August 28, 2013Completed
Condition(s):Granulomatosis With PolyangiitisLast Updated:April 13, 2021Recruiting
Condition(s):Myasthenia GravisLast Updated:May 23, 2017Completed
Condition(s):Granulomatosis With PolyangitisLast Updated:November 22, 2019Recruiting
Condition(s):IgA NephropathyLast Updated:July 14, 2017Unknown status
Condition(s):Multiple MyelomaLast Updated:August 27, 2020Active, not recruiting
Condition(s):Airway InflammationLast Updated:April 8, 2020Recruiting
Condition(s):Thyroid Associated OpthalmopathiesLast Updated:December 10, 2013Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.